A survey of knowledge and awareness of Jordanian female university students of human papillomavirus infection and its vaccine

Objective: To assess the knowledge and awareness of Jordanian female university students regarding human papillomavirus (HPV) infection and its vaccine. Materials and Methods: A self-administered, anonymous questionnaire was distributed to 450 participants at Jordan University of Science and Technology (JUST) in Jordan. The survey focused on three areas: knowledge and awareness of HPV infection, knowledge of HPV vaccine, and source of information about HPV infection and its vaccine. Results: The survey response rate was 79.8%. Most of the respondents (about 68%) have heard about HPV and knew that the HPV is a virus in the genital area that is sexually transmitted, and 59% of them knew that persistent infection with HPV virus can cause precancerous/cancerous diseases in the genital tract. Only 45% of the respondents have ever heard about HPV vaccine and 37.8% of them knew that HPV vaccine is very effective in preventing HPV infection and its related precancerous/cancerous diseases. Majority of the respondents, 78.7 % and 73.5%, who knew about HPV and HPV vaccine, respectively, had heard about it from healthcare providers. Conclusion: The study suggests that more health education and information about the HPV characteristics and HPV vaccine is needed for female university students.

Awareness; Human papillomavirus; Knowledge; university; Vaccine.

[1] Globocan 2012: “Estimated cancer incidence, mortality and prevalence worldwide in 2012”. Available at: http://globocan.iarc.fr/Default.aspx

[2] Wilson C.M., Tobin S., Young R.C.: “The exploding worldwidecancer burden: the impact of cancer on women”. Int. J. Gynecol. Cancer, 2004, 14, 1.

[3] Pitts M., Clarke T.: “Human papilomavirus infections and risks of cervical cancer:what do women know?” Health Edu. Res., 2002, 17, 706.

[4] Mistro A., Salamanca H., Trevisan R., Bertorelle R., Parenti A., Bonoldi E., et al.: “Human papillomavirus typing of invasive cervical cancers in Italy”. Infect. Agent Cancer, 2006, 1, 9.

[5] Koshiol J., Lindsay L., Pimenta J.M., Poole C., Jenkins D., Smith J.S.: “Persistent human papillomavirus infection and cervical neoplasia: a systematic review and metaanalysis”. Am. J. Epidemiol., 2008, 168, 123.

[6] Hausen H.: “Papillomaviruses and cancer: from basic studies to clinical application”. Nat. Rev. Cancer, 2002, 2, 342.

[7] Richardson H., Abrahamowicz M., Tellier P.P., Kelsall G., Berger R., Ferenczy A., et al.: “Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students”. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1149.

[8] Matos A., Moutinho J., Pinto D., Medeiros R.: ‘The influence of smoking and othercofactors on the time to onset cervical cancer in a southern European population”. Eur. J. Cancer Prev., 2005, 14, 485.

[9] Wong L.P., Sam I.C.: “Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV) vaccination and cervical cancer”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2010, 148, 90.

[10] Dell D.L., Chen H., Ahmad F., Stewart D.E.: “Knowledge about human papillomavirus among adolescents”. Obstet. Gynecol., 1990, 96, 653.

[11] Mays R.M., Zimet G.D., Winston Y., Kee R., Dickes J., Su L.: “Human papillomavirus,genital warts, Pap smears, and cervical cancer: Knowledge and beliefsof adolescent and dult women”. Health Care Women Int., 2000, 21, 361.

[12] Waller J., McCaffery K., Forrest S., Szarewski A., Cadman L., Wardle J.: “Awareness of human papillomavirus among women attending a well woman clinic”. Sex. Transm. Infect., 2003, 79, 320.

[13] Yacobi E., Tennant C., Ferrante J., Pal N., Roetzheim R.: “University students’ knowledge and awareness of HPV”. Prev. Med., 1999, 28, 535.

[14] Gerhardt C.A., Pong K., Kollar L.M., Hillard P.J., Rosenthal S.L.: “Adolescents’ knowledge ofhuman papillomavirus and cervical dysplasia”. J. Pediatr. Adolesc. Gynecol., 2000, 13, 15.

[15] Holcomb B., Bailey J.M., Crawford K., Ruffin M.T. 4th.: “Adults’ knowledge andbehaviors related to human papillomavirus infection”. J. Am. Board Family Pract., 2004, 17, 26.

[16] Ramirez J.E., Ramos D.M., Clayton L., Kanowitz S., Moscicki A.B.: “Genital human papillomavirus infections: Knowledge, perception of risk, and actual risk in anonclinic population of young women”. J. Women’s Health, 1997, 6, 113.

[17] Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al.: “Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial”. Lancet, 2004, 364, 1757.

[18] Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., RomanowskiB., Roteli-Martins C.M., et al.: “Sustained efficacy up to 4.5years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized controltrial”. Lancet, 2006, 367, 1247.

[19] Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., GiulianoA. R., et al.: “Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 Virus-like particle vaccine in young women: arandomized double-blind placebo-controlled multicenter phase II efficacy trial”. Lancet Oncol., 2005, 6, 271.

[20] Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J.,Iversen O.E., et al.: “High sustained efficacy of a prophylacticquadrivalenthuman papillomavirus types 6/11/16/18 L1 virus-like particle vaccinethrough 5 years of follow-up”. Br. J. Cancer, 2006, 95, 1459.

[21] Boyle P., Levin B.: “World Cancer Report 2008”. Lyon, France: World Health Organization, International Agency for Research on Cancer (IARC), 2008.

[22] Pitts M., Smith A., Croy S., Lyons A., Ryall R., Garland S., et al.: “Singaporean men'sknowledge of cervical cancer and human papillomavirus (HPV) and their attitudestowards HPV vaccination”. Vaccine, 2009, 27, 2989.

[23] Adams M., Jasani B., Fiander A.: “Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening”. Vaccine, 2007, 25, 3007.

[23] Baer H., Allen S., Braun L.: “Knowledge of human papillomavirus infection among young adult men and women: Implications for health education and research”. J. Commun. Health, 2000, 25, 67.

[24] McPartland T.S., Weaver B.A., Lee S., Koutsky L.A.: “Men’s perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer”. J. Am. Coll. Health, 2005, 53, 225.

[25] Lambert E.C.: “College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention”. J. Am. Board Fam. Pract.,2001, 14, 178.

[26] Anhang R., Stryker J.E., Wright T.C. Jr., Goldie S.J.: “News media coverage of human papillomavirus”. Cancer, 2004, 100, 308.